Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AJOONI.NS Stock Summary
Top 10 Correlated ETFs
AJOONI.NS
In the News
AJOONI.NS Financial details
Company Rating
Neutral
Market Cap
521.3M
Income
17.86M
Revenue
1.02B
Book val./share
23.48
Cash/share
0.78
Dividend
-
Dividend %
-
Employees
125
Optionable
No
Shortable
Yes
Earnings
-
P/E
10.01
Forward P/E
-
PEG
0.3
P/S
0.73
P/B
0.69
P/C
7.69
P/FCF
-13.07
Quick Ratio
0.19
Current Ratio
2.84
Debt / Equity
0.08
LT Debt / Equity
0.05
-
-
EPS (TTM)
0.77
EPS next Y
-
EPS next Q
-
EPS this Y
977.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
77.53%
Revenue last 5Y
13.4%
Revenue Q/Q
2.93%
EPS Q/Q
8.7%
-
-
-
-
SMA20
20%
SMA50
-14.29%
SMA100
20%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
4%
ROC
0.05%
Gross Margin
11%
Oper. Margin
2%
Profit Margin
1%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
3.85-7.7
52W High
-14.29%
52W Low
+100%
RSI
53
Rel Volume
1.86
Avg Volume
491.28K
Volume
913.81K
Perf Week
-0.83%
Perf Month
-2.44%
Perf Quarter
42.86%
Perf Half Y
31.87%
-
-
-
-
Beta
1.289
-
-
Volatility
0.05%, 0.36%
Prev Close
0%
Price
6
Change
1.69%
AJOONI.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 10.28 | 7.56 | 9 | 13.05 | 128.44 | |
Net income per share | 0.11 | 0.07 | 0.07 | 0.18 | 1.94 | |
Operating cash flow per share | -1.27 | -0.83 | 0.2 | 0.65 | -9.62 | |
Free cash flow per share | -1.35 | -1.09 | -0.42 | 0.27 | -14.55 | |
Cash per share | 0.2 | 0.04 | 0.07 | 0.03 | 0.85 | |
Book value per share | 3.15 | 3 | 2.76 | 2.89 | 71.85 | |
Tangible book value per share | 3.15 | 3 | 2.76 | 2.89 | 71.85 | |
Share holders equity per share | 3.15 | 3 | 2.76 | 2.89 | 71.85 | |
Interest debt per share | 0.23 | 1.01 | 1.28 | 1.04 | 9.75 | |
Market cap | 138.08M | 72.44M | 344.95M | 763.65M | 22.91M | |
Enterprise value | 138.49M | 121.46M | 410.34M | 816.58M | 71.58M | |
P/E ratio | 33.6 | 20.89 | 92.47 | 72.81 | 2.04 | |
Price to sales ratio | 0.35 | 0.18 | 0.68 | 1.03 | 0.03 | |
POCF ratio | -2.81 | -1.65 | 29.85 | 20.73 | -0.41 | |
PFCF ratio | -2.65 | -1.25 | -14.55 | 48.96 | -0.27 | |
P/B Ratio | 1.14 | 0.46 | 2.2 | 4.66 | 0.05 | |
PTB ratio | 1.14 | 0.46 | 2.2 | 4.66 | 0.05 | |
EV to sales | 0.35 | 0.3 | 0.8 | 1.1 | 0.1 | |
Enterprise value over EBITDA | 18.33 | 9.73 | 26.02 | 24.22 | 2.34 | |
EV to operating cash flow | -2.82 | -2.77 | 35.51 | 22.17 | -1.28 | |
EV to free cash flow | -2.66 | -2.1 | -17.3 | 52.35 | -0.85 | |
Earnings yield | 0.03 | 0.05 | 0.01 | 0.01 | 0.49 | |
Free cash flow yield | -0.38 | -0.8 | -0.07 | 0.02 | -3.68 | |
Debt to equity | 0.06 | 0.32 | 0.43 | 0.33 | 0.12 | |
Debt to assets | 0.04 | 0.22 | 0.24 | 0.18 | 0.09 | |
Net debt to EBITDA | 0.05 | 3.93 | 4.15 | 1.57 | 1.59 | |
Current ratio | 6.14 | 3 | 2.05 | 2.18 | 2.28 | |
Interest coverage | 2.88 | 2.44 | 2.2 | 4 | 4.13 | |
Income quality | -11.97 | -9.12 | 2.29 | 2.52 | -3.54 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0.24 | 0.2 | |
Capex to operating cash flow | 0.06 | 0.32 | -3.05 | -0.58 | 0.51 | |
Capex to revenue | -0.01 | -0.03 | -0.07 | -0.03 | -0.04 | |
Capex to depreciation | -0.65 | -3.99 | -8.07 | -1.91 | -2.85 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 2.74 | 2.1 | 2.02 | 3.47 | 55.99 | |
ROIC | 0.02 | 0.03 | 0.04 | 0.07 | 0.03 | |
Return on tangible assets | 0.02 | 0.02 | 0.01 | 0.05 | 0.02 | |
Graham Net | 0.22 | 0.82 | 0.44 | 0.44 | 9.25 | |
Working capital | 99.04M | 116.63M | 109.51M | 118.68M | 194.62M | |
Tangible asset value | 121.65M | 158.91M | 156.51M | 94.73M | 296.69M | |
Net current asset value | 57.46M | 103.32M | 90.54M | 92.91M | 176.09M | |
Invested capital | 0.06 | 0.32 | 0.43 | 0.33 | 0.12 | |
Average receivables | 24.17M | 88.72M | 143.05M | 158.43M | 202.85M | |
Average payables | 8.34M | 13.35M | 36.67M | 61M | 84.55M | |
Average inventory | 35.34M | 41.77M | 43.31M | 56.29M | 64.38M | |
Days sales outstanding | 44.42 | 117.71 | 112.28 | 78.81 | 120.47 | |
Days payables outstanding | 7.38 | 20.21 | 45.83 | 38.77 | 56.14 | |
Days of inventory on hand | 50.73 | 34.35 | 45.62 | 33.54 | 38.83 | |
Receivables turnover | 8.22 | 3.1 | 3.25 | 4.63 | 3.03 | |
Payables turnover | 49.48 | 18.06 | 7.96 | 9.41 | 6.5 | |
Inventory turnover | 7.2 | 10.63 | 8 | 10.88 | 9.4 | |
ROE | 0.03 | 0.02 | 0.02 | 0.06 | 0.03 | |
Capex per share | -0.07 | -0.26 | -0.62 | -0.37 | -4.93 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.07 | 4.71 | 11.99 | 11.12 | 11.44 | |
Net income per share | 0.06 | 0.06 | 0.23 | 0.23 | 0.25 | |
Operating cash flow per share | 0.3 | -0.6 | 0.24 | 0.24 | 0.24 | |
Free cash flow per share | 0.3 | -0.53 | 0.24 | 0.24 | 0.24 | |
Cash per share | 12.97 | 0.06 | 1.32 | 0.16 | 0.78 | |
Book value per share | 22.44 | 4.76 | 23.08 | 23.24 | 23.48 | |
Tangible book value per share | 22.44 | 4.76 | 23.08 | 23.24 | 23.48 | |
Share holders equity per share | 22.44 | 4.76 | 23.08 | 23.24 | 23.48 | |
Interest debt per share | 4.35 | 0.6 | 4.92 | 4.61 | 1.83 | |
Market cap | 109.52M | 346.07M | 73.6M | 78.85M | 115.65M | |
Enterprise value | -42.85M | 394.75M | 135.38M | 154.99M | 132.99M | |
P/E ratio | 25.33 | 16.04 | 4.58 | 4.87 | 6.57 | |
Price to sales ratio | 1.03 | 0.84 | 0.35 | 0.4 | 0.58 | |
POCF ratio | 20.7 | -6.55 | 17.6 | 18.48 | 27.1 | |
PFCF ratio | 20.7 | -7.48 | 17.6 | 18.48 | 27.1 | |
P/B Ratio | 0.28 | 0.83 | 0.18 | 0.19 | 0.28 | |
PTB ratio | 0.28 | 0.83 | 0.18 | 0.19 | 0.28 | |
EV to sales | -0.4 | 0.96 | 0.64 | 0.8 | 0.66 | |
Enterprise value over EBITDA | -8.63 | 32.77 | 20.36 | 24.37 | -20.23 | |
EV to operating cash flow | -8.1 | -7.47 | 32.37 | 36.31 | 31.16 | |
EV to free cash flow | -8.1 | -8.53 | 32.37 | 36.31 | 31.16 | |
Earnings yield | 0.01 | 0.02 | 0.05 | 0.05 | 0.04 | |
Free cash flow yield | 0.05 | -0.13 | 0.06 | 0.05 | 0.04 | |
Debt to equity | 0.19 | 0.12 | 0.21 | 0.19 | 0.08 | |
Debt to assets | 0.14 | 0.09 | 0.16 | 0.14 | 0.05 | |
Net debt to EBITDA | -30.69 | 4.04 | 9.29 | 11.97 | -2.64 | |
Current ratio | 3.66 | 2.28 | 2.84 | 2.53 | 2.72 | |
Interest coverage | 1.85 | 7.38 | 3.41 | 2.2 | -7.21 | |
Income quality | 4.89 | -9.8 | 1.04 | 1.05 | 0.97 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0.08 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0.01 | 0 | 0 | 0 | |
Intangibles to total assets | -0.02 | 0.2 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | -0.12 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0.02 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 2.77 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 5.58 | 2.57 | 10.91 | 10.99 | 11.51 | |
ROIC | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | |
Return on tangible assets | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | 13.05 | 0.61 | 3.61 | 5.34 | 5.74 | |
Working capital | 334.1M | 194.62M | 224.89M | 238.85M | 265.32M | |
Tangible asset value | 402.85M | 296.69M | 404.43M | 407.22M | 411.4M | |
Net current asset value | 315.88M | 176.09M | 207.24M | 222.09M | 243.85M | |
Invested capital | 0.19 | 0.12 | 0.21 | 0.19 | 0.08 | |
Average receivables | 143.08M | 199.57M | 216.28M | 234.68M | 278.22M | |
Average payables | 41.16M | 75.01M | 76.21M | 68.93M | 112.11M | |
Average inventory | 52.42M | 65.01M | 75.01M | 91.17M | 108.11M | |
Days sales outstanding | 129.79 | 53.63 | 80.01 | 130.59 | 122.9 | |
Days payables outstanding | 50.38 | 23.65 | 23.58 | 42.52 | 64.33 | |
Days of inventory on hand | 61.9 | 16.36 | 36.8 | 50.23 | 53.25 | |
Receivables turnover | 0.69 | 1.68 | 1.12 | 0.69 | 0.73 | |
Payables turnover | 1.79 | 3.81 | 3.82 | 2.12 | 1.4 | |
Inventory turnover | 1.45 | 5.5 | 2.45 | 1.79 | 1.69 | |
ROE | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex per share | 0 | 0.08 | 0 | 0 | 0 |
AJOONI.NS Frequently Asked Questions
What is Ajooni Biotech Limited stock symbol ?
Ajooni Biotech Limited is a IN stock and trading under the symbol AJOONI.NS
What is Ajooni Biotech Limited stock quote today ?
Ajooni Biotech Limited stock price is $6 today.
Is Ajooni Biotech Limited stock public?
Yes, Ajooni Biotech Limited is a publicly traded company.